Latest News and Press Releases

Leading European global therapeutics company more than 20,000 people selects Kneat to digitize its validation processes.

Medical devices and healthcare therapies maker signs 3-year Master Services Agreement with Kneat to streamline its computer systems validation processes.

ALTEN selects Kneat to digitize validation for itself and its customers.

Kneat achieves record results in growth and profitability, as third-quarter 2024 revenue and gross profit growth accelerate to 52% and 78% respectively,

Kneat signs a global and diverse medical devices manufacturer for digital validation.

Kneat to Announce 2024 Third-Quarter Financial Results November 6, 2024, and Host an Earnings Call on November 7

Kneat closed its previously announced bought deal, issuing 7,500,000 shares for gross proceeds to the Company of $35.6 million.

Another global pharmaceutical company selects Kneat to digitize its validation processes.

Kneat filed a final short-form prospectus, which qualifies the distribution of common shares in connection with its previously announced bought deal.

Kneat's Q2 2024 Growth Accelerates YoY, with Revenue up 45%, Annual Recurring Revenue up 60%, Gross Profit up 63%